{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:13:31Z","timestamp":1780758811156,"version":"3.54.1"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009634","name":"Susan G Komen Breast Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.mce.2021.111245","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T17:13:50Z","timestamp":1616260430000},"page":"111245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Breast cancer and the renin-angiotensin system (RAS): Therapeutic approaches and related metabolic diseases"],"prefix":"10.1016","volume":"528","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7335-6567","authenticated-orcid":false,"given":"Fl\u00e1via Sardela","family":"de Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3818-6990","authenticated-orcid":false,"given":"Jo\u00e3o Pedro T\u00f4rres","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalhara R.","family":"Menikdiwela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6501-0870","authenticated-orcid":false,"given":"Brennan","family":"Mabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-5294","authenticated-orcid":false,"given":"Rabin","family":"Dhakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhshanda layeequr","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7508-8030","authenticated-orcid":false,"given":"Naima","family":"Moustaid-Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mce.2021.111245_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128891","article-title":"Metabolic syndrome and breast cancer risk: a case-cohort study nested in a multicentre Italian cohort","volume":"10","author":"Agnoli","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111245_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3389\/fonc.2019.00765","article-title":"The many faces of obesity and its influence on breast cancer risk","volume":"9","author":"Agurs-Collins","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.mce.2021.111245_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12947-015-0011-x","article-title":"The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity","volume":"13","author":"Akolkar","year":"2015","journal-title":"Cardiovasc. Ultrasound"},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2014.14","article-title":"Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer","volume":"3","author":"Al-Ejeh","year":"2014","journal-title":"Oncogenesis"},{"key":"10.1016\/j.mce.2021.111245_bib5","doi-asserted-by":"crossref","first-page":"108244","DOI":"10.1016\/j.jnutbio.2019.108244","article-title":"Protective effects of eicosapentaenoic acid in adipocyte-breast cancer cell cross talk","volume":"75","author":"Al-Jawadi","year":"2020","journal-title":"J. Nutr. Biochem."},{"issue":"7","key":"10.1016\/j.mce.2021.111245_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1157\/13123996","article-title":"[Obesity, metabolic syndrome and diabetes: cardiovascular implications and therapy]","volume":"61","author":"Alegria Ezquerra","year":"2008","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.mce.2021.111245_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pharmthera.2018.02.001","article-title":"Targeting cancer stem cells in the clinic: current status and perspectives","volume":"187","author":"Annett","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/pr.118.017129","article-title":"Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure","volume":"71","author":"Arendse","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.mce.2021.111245_bib9","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1007\/s13277-015-3235-3","article-title":"Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer","volume":"36","author":"Arrieta","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.mce.2021.111245_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1178223419898458","article-title":"Linkage between obesity leptin and breast cancer","volume":"14","author":"Atoum","year":"2020","journal-title":"Breast Cancer (Auckl)"},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/0008-5472.CAN-13-0992","article-title":"A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells","volume":"74","author":"Barsoum","year":"2014","journal-title":"Canc. Res."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.RES.0000088358.99466.04","article-title":"Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells","volume":"93","author":"Benndorf","year":"2003","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.mce.2021.111245_bib13","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/cncr.11246","article-title":"Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma","volume":"97","author":"Bos","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.mce.2021.111245_bib14","doi-asserted-by":"crossref","first-page":"a003178","DOI":"10.1101\/cshperspect.a003178","article-title":"Hormone action in the mammary gland","volume":"2","author":"Brisken","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12885-018-4072-8","article-title":"The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors","volume":"18","author":"Bronsveld","year":"2018","journal-title":"BMC Canc."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015327","article-title":"The role of angiotensin-converting enzyme inhibitors and beta-blockers in primary prevention of cardiac dysfunction in breast cancer patients","volume":"9","author":"Brown","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib17","article-title":"Angiotensin 1-7 formation in breast tissue is attenuated in breast cancer - a study on the metabolism of angiotensinogen in breast cancer cell lines","volume":"70","author":"Bujak-Gizycka","year":"2019","journal-title":"J. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1113\/expphysiol.2005.030908","article-title":"Angiotensin II induces apoptosis in vivo in skeletal, as well as cardiac, muscle of the rat","volume":"90","author":"Burniston","year":"2005","journal-title":"Exp. Physiol."},{"issue":"11","key":"10.1016\/j.mce.2021.111245_bib19","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Canc. Res."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10549-014-3157-6","article-title":"Metabolic syndrome and outcomes following early-stage breast cancer","volume":"148","author":"Calip","year":"2014","journal-title":"Breast Canc. Res. Treat."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI112768","article-title":"Circulating and tissue angiotensin systems","volume":"79","author":"Campbell","year":"1987","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1172\/JCI112566","article-title":"Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat","volume":"78","author":"Campbell","year":"1986","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.mce.2021.111245_bib23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cellsig.2012.02.005","article-title":"Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium","volume":"24","author":"Carbajo-Lozoya","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.mce.2021.111245_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1741-7015-12-28","article-title":"Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts","volume":"12","author":"Cardwell","year":"2014","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.mce.2021.111245_bib25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1590\/0004-2730000003223","article-title":"Obesity, insulin resistance and comorbidities? Mechanisms of association","volume":"58","author":"Castro","year":"2014","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-014-3017-4","article-title":"Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth","volume":"146","author":"Catalano","year":"2014","journal-title":"Breast Canc. Res. Treat."},{"issue":"9","key":"10.1016\/j.mce.2021.111245_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/07357907.2011.616252","article-title":"Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and\/or statins","volume":"29","author":"Chae","year":"2011","journal-title":"Canc. Invest."},{"issue":"7","key":"10.1016\/j.mce.2021.111245_bib28","first-page":"549","article-title":"Use of ACE inhibitors and angiotensin receptor blockers and primary breast cancer outcomes","volume":"4","author":"Chae","year":"2013","journal-title":"J. Canc."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib29","first-page":"61","article-title":"Diabetes and breast cancer mortality in Black women","volume":"28","author":"Charlot","year":"2017","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.mce.2021.111245_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","article-title":"Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies","volume":"2","author":"Chauhan","year":"2011","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"10.1016\/j.mce.2021.111245_bib31","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.mce.2021.111245_bib32","doi-asserted-by":"crossref","first-page":"10674","DOI":"10.1073\/pnas.1819889116","article-title":"Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy","volume":"116","author":"Chauhan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cncr.26144","article-title":"Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer","volume":"118","author":"Chavez-Macgregor","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s13277-013-1043-1","article-title":"Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model","volume":"35","author":"Chen","year":"2014","journal-title":"Tumour Biol"},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3857\/roj.2016.01816","article-title":"Immunomodulatory effect of captopril and local irradiation on myeloid-derived suppressor cells","volume":"34","author":"Cho","year":"2016","journal-title":"Radiat. Oncol. J"},{"issue":"8","key":"10.1016\/j.mce.2021.111245_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080857","article-title":"The effects of adipocytes on the regulation of breast cancer in the tumor microenvironment: an update","volume":"8","author":"Chu","year":"2019","journal-title":"Cells"},{"issue":"16","key":"10.1016\/j.mce.2021.111245_bib37","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1002\/cncr.31569","article-title":"Effect of exercise on metabolic syndrome in black women by family history and predicted risk of breast cancer: the FIERCE Study","volume":"124","author":"Dash","year":"2018","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.physbeh.2010.03.018","article-title":"The renin angiotensin system and the metabolic syndrome","volume":"100","author":"de Kloet","year":"2010","journal-title":"Physiol. Behav."},{"issue":"18","key":"10.1016\/j.mce.2021.111245_bib40","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.ejca.2008.09.013","article-title":"Her2-positive breast cancer: herceptin and beyond","volume":"44","author":"Dean-Colomb","year":"2008","journal-title":"Eur. J. Canc."},{"issue":"6","key":"10.1016\/j.mce.2021.111245_bib41","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s13277-010-0072-2","article-title":"Mammary renin-angiotensin system-regulating aminopeptidase activities are modified in rats with breast cancer","volume":"31","author":"del Pilar Carrera","year":"2010","journal-title":"Tumour Biol"},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib42","first-page":"52","article-title":"Breast cancer statistics","volume":"64","author":"DeSantis","year":"2013","journal-title":"CA A Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.mce.2021.111245_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","article-title":"Angiotensin receptors: a new role in cancer?","volume":"16","author":"Deshayes","year":"2005","journal-title":"Trends Endocrinol. Metabol."},{"issue":"9","key":"10.1016\/j.mce.2021.111245_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090299","article-title":"Metabolic syndrome and the risk of breast cancer and subtypes by race, menopause and BMI","volume":"10","author":"Dibaba","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.mce.2021.111245_bib45","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.1018892108","article-title":"Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors","volume":"108","author":"Diop-Frimpong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib46","first-page":"1029","article-title":"Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis","volume":"146","author":"Dvorak","year":"1995","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI16645","article-title":"Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth","volume":"112","author":"Egami","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib48","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.4081\/ejtm.2019.8776","article-title":"Investigation of the association between metabolic syndrome and breast cancer patients","volume":"30","author":"Eskandari","year":"2020","journal-title":"Eur J Transl Myol"},{"issue":"6","key":"10.1016\/j.mce.2021.111245_bib49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"issue":"7355","key":"10.1016\/j.mce.2021.111245_bib50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib52","first-page":"2578","article-title":"Pathological assessment of response to induction chemotherapy in breast cancer","volume":"46","author":"Feldman","year":"1986","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2021.111245_bib53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1054-3589(10)59007-0","article-title":"Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7)","volume":"59","author":"Ferrario","year":"2010","journal-title":"Adv. Pharmacol."},{"issue":"8","key":"10.1016\/j.mce.2021.111245_bib54","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib55","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.mce.2021.111245_bib56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev-pharmtox-070115-095427","article-title":"Epidermal growth factor receptor transactivation: mechanisms, pathophysiology, and potential therapies in the cardiovascular system","volume":"56","author":"Forrester","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"7","key":"10.1016\/j.mce.2021.111245_bib57","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/dmrr.2795","article-title":"Metabolic syndrome and pre-diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways","volume":"32","author":"Gallagher","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020089","article-title":"Metabolic reprogramming in breast cancer and its therapeutic implications","volume":"8","author":"Gandhi","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10549-011-1505-3","article-title":"Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort","volume":"129","author":"Ganz","year":"2011","journal-title":"Breast Canc. Res. Treat."},{"issue":"12","key":"10.1016\/j.mce.2021.111245_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121822","article-title":"Immunotherapy: a challenge of breast cancer treatment","volume":"11","author":"Garcia-Aranda","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.mce.2021.111245_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123950","article-title":"Bcl-2 inhibition to overcome resistance to chemo- and immunotherapy","volume":"19","author":"Garcia-Aranda","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.mce.2021.111245_bib62","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The renin-angiotensin system and cancer: old dog, new tricks","volume":"10","author":"George","year":"2010","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.mce.2021.111245_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mce.2017.09.014","article-title":"Obesity and breast cancer - role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue","volume":"466","author":"Gerard","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1200\/JCO.2002.20.1.42","article-title":"Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study","volume":"20","author":"Goodwin","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.mce.2021.111245_bib65","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.1158\/0008-5472.CAN-06-0017","article-title":"Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts","volume":"66","author":"Hartman","year":"2006","journal-title":"Canc. Res."},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib66","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1148\/radiology.176.3.2167500","article-title":"Early breast cancer: detection of recurrence after conservative surgery and radiation therapy","volume":"176","author":"Hassell","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.mce.2021.111245_bib67","doi-asserted-by":"crossref","first-page":"548436","DOI":"10.1155\/2015\/548436","article-title":"Recent advances in the use of metformin: can treating diabetes prevent breast cancer?","volume":"2015","author":"Hatoum","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"19","key":"10.1016\/j.mce.2021.111245_bib68","first-page":"4089","article-title":"Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignancies","volume":"20","author":"Haznedaroglu","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib69","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-013-2553-7","article-title":"Beta blockers and angiotensin-converting enzyme inhibitors' purported benefit on breast cancer survival may be explained by aspirin use","volume":"139","author":"Holmes","year":"2013","journal-title":"Breast Canc. Res. Treat."},{"issue":"43","key":"10.1016\/j.mce.2021.111245_bib70","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.mce.2021.111245_bib71","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1158\/0008-5472.CAN-12-4354","article-title":"Vascular normalization as an emerging strategy to enhance cancer immunotherapy","volume":"73","author":"Huang","year":"2013","journal-title":"Canc. Res."},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mce.2014.11.015","article-title":"Estrogen receptors in breast carcinogenesis and endocrine therapy","volume":"418","author":"Huang","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib73","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00228-018-2593-3","article-title":"Role of metformin in overweight and obese people without diabetes: a systematic review and network meta-analysis","volume":"75","author":"Hui","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib74","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.bjc.6602961","article-title":"Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival","volume":"94","author":"Ino","year":"2006","journal-title":"Br. J. Canc."},{"issue":"17","key":"10.1016\/j.mce.2021.111245_bib75","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers","volume":"31","author":"Jain","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib76","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","article-title":"Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Canc. Cell"},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib77","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s12253-012-9516-x","article-title":"Angiotensin II type 1 receptor (AT-1R) expression correlates with VEGF-A and VEGF-D expression in invasive ductal breast cancer","volume":"18","author":"Jethon","year":"2012","journal-title":"Pathol. Oncol. Res."},{"issue":"9","key":"10.1016\/j.mce.2021.111245_bib78","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1007\/s13277-015-3380-8","article-title":"Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study","volume":"36","author":"Juanjuan","year":"2015","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib79","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","article-title":"The renin-angiotensin system: a link between obesity, inflammation and insulin resistance","volume":"13","author":"Kalupahana","year":"2012","journal-title":"Obes. Rev."},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib80","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/10409238.2012.694843","article-title":"The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms","volume":"47","author":"Kalupahana","year":"2012","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/oby.2011.299","article-title":"Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance","volume":"20","author":"Kalupahana","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib82","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mam.2011.10.011","article-title":"Immunity as a link between obesity and insulin resistance","volume":"33","author":"Kalupahana","year":"2012","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.mce.2021.111245_bib83","doi-asserted-by":"crossref","first-page":"943162","DOI":"10.1155\/2014\/943162","article-title":"A comprehensive review on metabolic syndrome","volume":"2014","author":"Kaur","year":"2014","journal-title":"Cardiol. Res. Pract."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib84","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/bcr314","article-title":"Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis","volume":"3","author":"Knowles","year":"2001","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.mce.2021.111245_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061686","article-title":"Obesity and breast cancer: a case of inflamed adipose tissue","volume":"12","author":"Kolb","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.mce.2021.111245_bib86","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013183","article-title":"Ethnic disparities in the prevalence of metabolic syndrome and its risk factors in the Suriname Health Study: a cross-sectional population study","volume":"6","author":"Krishnadath","year":"2016","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.mce.2021.111245_bib87","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11892-015-0666-6","article-title":"Mind the gap: race\/ethnic and socioeconomic disparities in obesity","volume":"15","author":"Krueger","year":"2015","journal-title":"Curr. Diabetes Rep."},{"issue":"26","key":"10.1016\/j.mce.2021.111245_bib88","doi-asserted-by":"crossref","first-page":"23107","DOI":"10.1074\/jbc.C200201200","article-title":"Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activation","volume":"277","author":"Le","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.mce.2021.111245_bib89","first-page":"1375","article-title":"The renin-angiotensin system blockers as adjunctive therapy for cancer: a meta-analysis of survival outcome","volume":"21","author":"Li","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib90","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/bcr1509","article-title":"Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1","volume":"8","author":"Lim","year":"2006","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib91","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-014-3146-9","article-title":"Diabetes, diabetes treatment and breast cancer prognosis","volume":"148","author":"Luo","year":"2014","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.mce.2021.111245_bib92","doi-asserted-by":"crossref","DOI":"10.1177\/1178223418774802","article-title":"Breast cancer immunotherapy: an update","volume":"12","author":"Makhoul","year":"2018","journal-title":"Breast Cancer (Auckl)"},{"issue":"11","key":"10.1016\/j.mce.2021.111245_bib93","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/ijc.29315","article-title":"Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study","volume":"136","author":"McKenzie","year":"2015","journal-title":"Int. J. Canc."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib94","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbadis.2014.05.005","article-title":"Autophagy and oxidative stress in cardiovascular diseases","volume":"1852","author":"Mei","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib95","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1038\/s41598-019-44834-8","article-title":"Angiotensin II increases endoplasmic reticulum stress in adipose tissue and adipocytes","volume":"9","author":"Menikdiwela","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib96","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41419-020-2275-9","article-title":"Autophagy in metabolic syndrome: breaking the wheel by targeting the renin-angiotensin system","volume":"11","author":"Menikdiwela","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.mce.2021.111245_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061327","article-title":"Role of microRNA 690 in mediating angiotensin II effects on inflammation and endoplasmic reticulum stress","volume":"9","author":"Menikdiwela","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.mce.2021.111245_bib98","first-page":"9","article-title":"Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study","volume":"5","author":"Moey","year":"2019","journal-title":"Cardiooncology"},{"key":"10.1016\/j.mce.2021.111245_bib99","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.5888\/pcd14.160287","article-title":"Metabolic syndrome prevalence by race\/ethnicity and sex in the United States, national health and nutrition examination survey, 1988-2012","volume":"14","author":"Moore","year":"2017","journal-title":"Prev. Chronic Dis."},{"issue":"16","key":"10.1016\/j.mce.2021.111245_bib100","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/cncr.30079","article-title":"Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers","volume":"122","author":"Morris","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087377","article-title":"Activation of ERalpha signaling differentially modulates IFN-gamma induced HLA-class II expression in breast cancer cells","volume":"9","author":"Mostafa","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib102","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ijc.28128","article-title":"Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia","volume":"133","author":"Murphy","year":"2013","journal-title":"Int. J. Canc."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib103","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/cas.13423","article-title":"Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment","volume":"109","author":"Nakamura","year":"2018","journal-title":"Canc. Sci."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib104","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.biopha.2014.05.004","article-title":"The role of captopril and losartan in prevention and regression of tamoxifen-induced resistance of breast cancer cell line MCF-7: an in vitro study","volume":"68","author":"Namazi","year":"2014","journal-title":"Biomed. Pharmacother."},{"issue":"25","key":"10.1016\/j.mce.2021.111245_bib105","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mce.2021.111245_bib106","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/ijc.29940","article-title":"A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis","volume":"138","author":"Nechuta","year":"2016","journal-title":"Int. J. Canc."},{"issue":"9","key":"10.1016\/j.mce.2021.111245_bib107","first-page":"2497","article-title":"Role of extracellular matrix assembly in interstitial transport in solid tumors","volume":"60","author":"Netti","year":"2000","journal-title":"Canc. Res."},{"issue":"6","key":"10.1016\/j.mce.2021.111245_bib108","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.ijo.0803528","article-title":"Oestrogen receptor alpha gene expression levels are reduced in obese compared to normal weight females","volume":"31","author":"Nilsson","year":"2007","journal-title":"Int. J. Obes."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib109","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib110","first-page":"163","article-title":"Final results of a phase II trial of preoperative TAC (docetaxel\/doxorubicin\/cyclophosphamide) in stage III breast cancer","volume":"6","author":"O'Regan","year":"2005","journal-title":"Clin. Breast Canc"},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib111","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/bcr2856","article-title":"Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study","volume":"13","author":"Oh","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"8","key":"10.1016\/j.mce.2021.111245_bib112","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"Ohlund","year":"2014","journal-title":"J. Exp. Med."},{"issue":"9310","key":"10.1016\/j.mce.2021.111245_bib113","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(02)08024-8","article-title":"Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study","volume":"359","author":"Onder","year":"2002","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.mce.2021.111245_bib114","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJM199811263392207","article-title":"Tamoxifen in the treatment of breast cancer","volume":"339","author":"Osborne","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2021.111245_bib115","first-page":"32","article-title":"Estrogen receptors in breast cancer therapy","volume":"3","author":"Osborne","year":"1996","journal-title":"Sci. Med."},{"issue":"26","key":"10.1016\/j.mce.2021.111245_bib116","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib117","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/j.2040-4603.2017.tb00776.x","article-title":"Regulation and functions of the renin-angiotensin system in white and Brown adipose tissue","volume":"7","author":"Pahlavani","year":"2017","journal-title":"Comp. Physiol."},{"issue":"8","key":"10.1016\/j.mce.2021.111245_bib118","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1200\/JCO.1998.16.8.2625","article-title":"Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries","volume":"16","author":"Paszat","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib119","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/bcr2901","article-title":"Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study","volume":"13","author":"Patnaik","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"5 Suppl. l","key":"10.1016\/j.mce.2021.111245_bib120","article-title":"Diabetes health disparities: a systematic review of health care interventions","volume":"64","author":"Peek","year":"2007","journal-title":"Med. Care Res. Rev."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib121","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13046-017-0542-0","article-title":"Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer","volume":"36","author":"Pei","year":"2017","journal-title":"J. Exp. Clin. Canc. Res."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib122","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/ijbs.28304","article-title":"G protein-coupled estrogen receptor 1 inhibits angiotensin II-induced cardiomyocyte hypertrophy via the regulation of PI3K-Akt-mTOR signalling and autophagy","volume":"15","author":"Pei","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib123","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4161\/cbt.9.4.10643","article-title":"Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells","volume":"9","author":"Pickel","year":"2010","journal-title":"Canc. Biol. Ther."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib124","first-page":"378","article-title":"Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention","volume":"67","author":"Picon-Ruiz","year":"2017","journal-title":"CA A Cancer J. Clin."},{"issue":"410","key":"10.1016\/j.mce.2021.111245_bib125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5616","article-title":"Targeting the renin-angiotensin system to improve cancer treatment: implications for immunotherapy","volume":"9","author":"Pinter","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.mce.2021.111245_bib126","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1158\/1078-0432.CCR-18-0236","article-title":"Renin-angiotensin system inhibitors to mitigate cancer treatment-related adverse events","volume":"24","author":"Pinter","year":"2018","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2021.111245_bib127","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.matbio.2016.05.003","article-title":"Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules","volume":"56","author":"Piperigkou","year":"2016","journal-title":"Matrix Biol."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1158\/1535-7163.647.3.5","article-title":"Hypoxia inducible factor-1alpha as a cancer drug target","volume":"3","author":"Powis","year":"2004","journal-title":"Mol. Canc. Therapeut."},{"issue":"11","key":"10.1016\/j.mce.2021.111245_bib129","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/01.CIR.0000141736.76561.78","article-title":"Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome","volume":"110","author":"Prasad","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.mce.2021.111245_bib130","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrendo.2011.122","article-title":"The G-protein-coupled estrogen receptor GPER in health and disease","volume":"7","author":"Prossnitz","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib131","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1677\/erc.1.01136","article-title":"The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion","volume":"13","author":"Puddefoot","year":"2006","journal-title":"Endocr. Relat. Canc."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib132","first-page":"45","article-title":"Our ACE in the HOLE: justifying the use of angiotensin-converting enzyme inhibitors as adjuvants to standard chemotherapy","volume":"38","author":"Radin","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mce.2021.111245_bib133","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.2147\/DMSO.S257797","article-title":"Endoplasmic reticulum (ER) stress in Part Mediates effects of angiotensin II in pancreatic beta cells","volume":"13","author":"Ramalingam","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib134","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.maturitas.2012.02.007","article-title":"Neoadjuvant chemotherapy modifies serum angiotensinase activities in women with breast cancer","volume":"72","author":"Ramirez-Exposito","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.mce.2021.111245_bib135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.breast.2018.10.010","article-title":"Circulating renin-angiotensin system-regulating specific aminopeptidase activities in pre- and post- menopausal women with breast cancer treated or not with neoadyuvant chemotherapy. A two years follow up study","volume":"43","author":"Ramirez-Exposito","year":"2019","journal-title":"Breast"},{"issue":"12","key":"10.1016\/j.mce.2021.111245_bib136","doi-asserted-by":"crossref","first-page":"R653","DOI":"10.1530\/ERC-19-0314","article-title":"Mechanisms linking the renin-angiotensin system, obesity, and breast cancer","volume":"26","author":"Rasha","year":"2019","journal-title":"Endocr. Relat. Canc."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib137","doi-asserted-by":"crossref","first-page":"112114","DOI":"10.1016\/j.yexcr.2020.112114","article-title":"Renin angiotensin system inhibition attenuates adipocyte-breast cancer cell interactions","volume":"394","author":"Rasha","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010220","article-title":"Combined effects of eicosapentaenoic acid and adipocyte renin-angiotensin system inhibition on breast cancer cell inflammation and migration","volume":"12","author":"Rasha","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.mce.2021.111245_bib139","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"issue":"25","key":"10.1016\/j.mce.2021.111245_bib140","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.1073\/pnas.0900351106","article-title":"AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist","volume":"106","author":"Rhodes","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib141","first-page":"787","article-title":"The renin-angiotensin system and diabetes: an update","volume":"4","author":"Ribeiro-Oliveira","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"issue":"8","key":"10.1016\/j.mce.2021.111245_bib142","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib143","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00280-005-0078-4","article-title":"Phase I\/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer","volume":"57","author":"Rodgers","year":"2006","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.mce.2021.111245_bib144","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2015.00024","article-title":"G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?","volume":"6","author":"Rodrigues-Ferreira","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/biof.1109","article-title":"Biochemical and molecular mechanisms for the association between obesity, chronic inflammation, and breast cancer","volume":"40","author":"Rose","year":"2014","journal-title":"Biofactors"},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib146","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1467-789X.2004.00142.x","article-title":"Obesity, adipocytokines, and insulin resistance in breast cancer","volume":"5","author":"Rose","year":"2004","journal-title":"Obes. Rev."},{"key":"10.1016\/j.mce.2021.111245_bib147","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fonc.2019.00745","article-title":"Therapeutic targeting of cancer stem cells via modulation of the renin-angiotensin system","volume":"9","author":"Roth","year":"2019","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib148","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2005.02.007","article-title":"Angiotensin II directly inhibits protein synthesis in murine myotubes","volume":"231","author":"Russell","year":"2006","journal-title":"Canc. Lett."},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib149","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1470320312465218","article-title":"Chemotherapy and radiation regimens to breast cancer treatment induce changes in mRNA levels of renin-angiotensin system related genes in cardiac tissue","volume":"14","author":"Salata","year":"2013","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bjc.6602725","article-title":"Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia","volume":"93","author":"Sanders","year":"2005","journal-title":"Br. J. Canc."},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib151","first-page":"297","article-title":"Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome","volume":"180","author":"Sataloff","year":"1995","journal-title":"J. Am. Coll. Surg."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib152","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.smim.2008.07.001","article-title":"Specificity in cancer immunotherapy","volume":"20","author":"Schietinger","year":"2008","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.mce.2021.111245_bib153","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2018.01.020","article-title":"Integrins in wound healing, fibrosis and tumor stroma: high potential targets for therapeutics and drug delivery","volume":"129","author":"Schnittert","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib154","article-title":"Renin-angiotensin system blockade for the risk of cancer and death","volume":"17","author":"Shen","year":"2016","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib155","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.urology.2010.11.002","article-title":"Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer","volume":"77","author":"Shirotake","year":"2011","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib156","first-page":"7","article-title":"Cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA A Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib157","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1634\/theoncologist.2015-0351","article-title":"Obesity and breast cancer: molecular interconnections and potential clinical applications","volume":"21","author":"Simone","year":"2016","journal-title":"Oncol."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib158","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/me.2013-1011","article-title":"Minireview: obesity and breast cancer: a tale of inflammation and dysregulated metabolism","volume":"27","author":"Simpson","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2021.111245_bib159","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2014.00023","article-title":"Tissue Renin-Angiotensin systems: a unifying hypothesis of metabolic disease","volume":"5","author":"Skov","year":"2014","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","article-title":"Combination cancer immunotherapies tailored to the tumour microenvironment","volume":"13","author":"Smyth","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mce.2021.111245_bib161","unstructured":"Society, A.C., Breast Cancer Facts & Figures 2019\u20132020. Am. Cancer Soc, 2019: p. 1-44."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib162","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13046-017-0545-x","article-title":"ERbeta1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1","volume":"36","author":"Song","year":"2017","journal-title":"J. Exp. Clin. Canc. Res."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib163","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.38","article-title":"Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1","volume":"8","author":"Song","year":"2017","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib164","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s13046-019-1359-9","article-title":"Estrogen receptor beta inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy","volume":"38","author":"Song","year":"2019","journal-title":"J. Exp. Clin. Canc. Res."},{"issue":"13","key":"10.1016\/j.mce.2021.111245_bib165","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1200\/JCO.2016.69.7722","article-title":"Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2-positive primary breast cancer: analysis from the ALTTO phase III randomized trial","volume":"35","author":"Sonnenblick","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.mce.2021.111245_bib166","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1200\/JCO.2012.43.9190","article-title":"Use of beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study","volume":"31","author":"Sorensen","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib167","first-page":"124","article-title":"A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer","volume":"9","author":"Stearns","year":"2003","journal-title":"Clin. Canc. Res."},{"issue":"7","key":"10.1016\/j.mce.2021.111245_bib168","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1158\/0008-5472.CAN-12-1699","article-title":"Genetic susceptibility to triple-negative breast cancer","volume":"73","author":"Stevens","year":"2013","journal-title":"Canc. Res."},{"issue":"11","key":"10.1016\/j.mce.2021.111245_bib169","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1470-2045(15)00223-5","article-title":"Global cancer surgery: delivering safe, affordable, and timely cancer surgery","volume":"16","author":"Sullivan","year":"2015","journal-title":"Lancet Oncol."},{"issue":"13","key":"10.1016\/j.mce.2021.111245_bib170","article-title":"Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: evidence from a meta-analysis including 55 studies","volume":"96","author":"Sun","year":"2017","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib171","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0167-0115(92)90527-2","article-title":"Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor","volume":"40","author":"Swanson","year":"1992","journal-title":"Regul. Pept."},{"key":"10.1016\/j.mce.2021.111245_bib172","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-319-70197-4_10","article-title":"Immune checkpoint blockade for breast cancer","volume":"173","author":"Swoboda","year":"2018","journal-title":"Canc. Treat Res."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib173","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrclinonc.2012.203","article-title":"Past, present, and future of radiotherapy for the benefit of patients","volume":"10","author":"Thariat","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib174","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/me.2009-0254","article-title":"Physiological genomics identifies estrogen-related receptor alpha as a regulator of renal sodium and potassium homeostasis and the renin-angiotensin pathway","volume":"24","author":"Tremblay","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"7","key":"10.1016\/j.mce.2021.111245_bib175","first-page":"RA130","article-title":"Diabetes mellitus: complications and therapeutics","volume":"12","author":"Tripathi","year":"2006","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.mce.2021.111245_bib176","doi-asserted-by":"crossref","first-page":"678756","DOI":"10.1155\/2015\/678756","article-title":"Use of insulin and mortality from breast cancer among Taiwanese women with diabetes","volume":"2015","author":"Tseng","year":"2015","journal-title":"J Diabetes Res"},{"issue":"21","key":"10.1016\/j.mce.2021.111245_bib177","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1038\/sj.onc.1206385","article-title":"The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy","volume":"22","author":"Unruh","year":"2003","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.mce.2021.111245_bib178","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1167\/iovs.07-0964","article-title":"Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor","volume":"49","author":"Usui","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"84","key":"10.1016\/j.mce.2021.111245_bib179","doi-asserted-by":"crossref","first-page":"35500","DOI":"10.18632\/oncotarget.26174","article-title":"Renin-angiotensin inhibitors reprogram tumor immune microenvironment: a comprehensive view of the influences on anti-tumor immunity","volume":"9","author":"Vallejo-Ardila","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib180","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2796.2005.01531.x","article-title":"Metformin improves endothelial function in patients with metabolic syndrome","volume":"258","author":"Vitale","year":"2005","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.mce.2021.111245_bib181","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/bcr287","article-title":"The complexities of breast cancer desmoplasia","volume":"3","author":"Walker","year":"2001","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mce.2021.111245_bib182","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7819-11-71","article-title":"Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China","volume":"11","author":"Wang","year":"2013","journal-title":"World J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib183","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/jdi.13112","article-title":"Increasing risk of diabetes mellitus in postmenopausal women with newly diagnosed primary breast cancer","volume":"11","author":"Wang","year":"2020","journal-title":"J Diabetes Investig"},{"issue":"12","key":"10.1016\/j.mce.2021.111245_bib184","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26788","article-title":"The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration","volume":"2","author":"Watt","year":"2013","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.mce.2021.111245_bib185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41523-020-0162-2","article-title":"Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype","volume":"6","author":"Wilson","year":"2020","journal-title":"NPJ Breast Cancer"},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib186","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1055-9965.EPI-14-1140","article-title":"Diabetes and other comorbidities in breast cancer survival by race\/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC)","volume":"24","author":"Wu","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.mce.2021.111245_bib187","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3389\/fendo.2019.00905","article-title":"Metabolic syndrome, and particularly the hypertriglyceridemic-waist phenotype, increases breast cancer risk, and adiponectin is a potential mechanism: a case-control study in Chinese women","volume":"10","author":"Xiang","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2021.111245_bib188","doi-asserted-by":"crossref","first-page":"42396","DOI":"10.1038\/srep42396","article-title":"Hypoxia-induced angiotensin II by the lactate-chymase-dependent mechanism mediates radioresistance of hypoxic tumor cells","volume":"7","author":"Xie","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib189","doi-asserted-by":"crossref","first-page":"H1770","DOI":"10.1152\/ajpheart.01011.2005","article-title":"Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice","volume":"292","author":"Xue","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.mce.2021.111245_bib190","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.canlet.2016.04.006","article-title":"Downregulation of ACE2\/Ang-(1-7)\/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry","volume":"376","author":"Yu","year":"2016","journal-title":"Canc. Lett."},{"key":"10.1016\/j.mce.2021.111245_bib191","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.peptides.2013.04.014","article-title":"Angiotensin III: a physiological relevant peptide of the renin angiotensin system","volume":"46","author":"Yugandhar","year":"2013","journal-title":"Peptides"},{"issue":"49","key":"10.1016\/j.mce.2021.111245_bib192","article-title":"Diabetes mellitus and prognosis in women with breast cancer: a systematic review and meta-analysis","volume":"95","author":"Zhao","year":"2016","journal-title":"Medicine (Baltim.)"},{"issue":"4","key":"10.1016\/j.mce.2021.111245_bib193","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1745-7270.2008.00402.x","article-title":"Angiotensin II suppresses adriamycin-induced apoptosis through activation of phosphatidylinositol 3-kinase\/Akt signaling in human breast cancer cells","volume":"40","author":"Zhao","year":"2008","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"5","key":"10.1016\/j.mce.2021.111245_bib194","first-page":"679","article-title":"Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry","volume":"27","author":"Zhao","year":"2016","journal-title":"Cancer Causes Control"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720721000897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720721000897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:17:28Z","timestamp":1759587448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720721000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":194,"alternative-id":["S0303720721000897"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2021.111245","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer and the renin-angiotensin system (RAS): Therapeutic approaches and related metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2021.111245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111245"}}